Synthesis of photoswitchable Δ9-tetrahydrocannabinol derivatives enables 
optical control of cannabinoid receptor 1 signaling

Westphal, Matthias V.; Schafroth, Michael A.; Sarott, Roman C.; Imhof, Michael A.; Bold, Christian P.; Leippe, Philipp; Dhopeshwarkar, Amey; Grandner, Jessica M.; Katritch, Vsevolod; Mackie, OrcidKen; Trauner, Dirk; Carreira, Erick M.; Frank, James A.

doi:10.1021/jacs.7b06456

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Synthesis of photoswitchable Δ9-tetrahydrocannabinol derivatives enables optical control of cannabinoid receptor 1 signaling

MPS-Authors

/persons/resource/persons302519

Sarott, Roman C.
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

External Resource

https://pubs.acs.org/doi/10.1021/jacs.7b06456
(全文テキスト（全般）)

https://pubs.acs.org/doi/epdf/10.1021/jacs.7b06456?ref=article_openPDF
(全文テキスト（全般）)

https://pubs.acs.org/doi/suppl/10.1021/jacs.7b06456/suppl_file/ja7b06456_si_001.pdf
(付録資料)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Westphal, M. V., Schafroth, M. A., Sarott, R. C., Imhof, M. A., Bold, C. P., Leippe, P., Dhopeshwarkar, A., Grandner, J. M., Katritch, V., Mackie, O., Trauner, D., Carreira, E. M., & Frank, J. A. (2017). Synthesis of photoswitchable Δ9-tetrahydrocannabinol derivatives enables optical control of cannabinoid receptor 1 signaling. Journal of the American Chemical Society, 139(50), 18206-18212. doi:10.1021/jacs.7b06456.

引用: https://hdl.handle.net/21.11116/0000-000F-F560-0

要旨

The cannabinoid receptor 1 (CB1) is an inhibitory G protein-coupled receptor abundantly expressed in the central nervous system. It has rich pharmacology and largely accounts for the recreational use of cannabis. We describe efficient asymmetric syntheses of four photoswitchable Δ9-tetrahydrocannabinol derivatives (azo-THCs) from a central building block 3-Br-THC. Using electrophysiology and a FRET-based cAMP assay, two compounds are identified as potent CB1 agonists that change their effect upon illumination. As such, azo-THCs enable CB1-mediated optical control of inwardly rectifying potassium channels, as well as adenylyl cyclase.